Author

Gunhild Mari Mælandsmo

Oslo University HospitalORCID 0000-0002-4797-1600Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Eivind Valen EgelandiD· 2 shared Lina PrasmickaiteiD· 2 shared Allison CreasoniD· 1 shared Amanda PoissonnieriD· 1 shared Andrea ČumováiD· 1 shared Andrea ŠoltýsováiD· 1 shared Andrej FicekiD· 1 shared Arild Holth· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Eivind Valen EgelandORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade

Ieva Ailte, Sudhir Kumar Chauhan, Lina Prasmickaite, Assia V. Bassarova, Amanda Poissonnier, Marike Feenstra, Marta Nyakas, Bjarne Johannessen, Truls Ryder, Robert Hermann, Lars Henrik Frich, Arild Holth, Else Marit Inderberg, Henrik Jespersen, Viví Ann Flørenes, , Eivind Valen Egeland

This study identifies CD38hiCD19dim cells in lymph nodes as a prognostic marker for improved outcomes in stage III melanoma patients receiving PD-1 blockade.

Frontiers in Oncology · May 4, 2026Peer-reviewedCancer Biology

Development of Paclitaxel Resistance in Triple-Negative Breast Cancer Is Associated with Extensive DNA Methylation Changes That Are Partially Reversed by Decitabine

Lenka Trnkova, Monika Buríková, Andrea Šoltýsová, Andrej Ficek, Jana Plavá, Andrea Čumová, Lucia Rojikova, Kristína Jakič, Eva Sedláčková, Boris Tichý, Vojtěch Bystrý, Florence Busato, Yimin Shen, Miroslava Matúšková, Lucia Kučerová, , Božena Smolková

This study shows that paclitaxel resistance in triple-negative breast cancer is linked to DNA methylation changes, which can be partially reversed by decitabine to enhance chemosensitivity.

Drug Resistance Updates · Jan 2, 2026Peer-reviewedCancer Biology

Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer: remodeling during treatment and associations with clinical response

Maria Aanesland Dahle, Jan-Lukas Førde, Eivind Valen Egeland, Allison Creason, Cameron Watson, Øystein Garred, Lina Prasmickaite, Gunhild Mari Mælandsmo, Gordon Brent Mills, Olav Engebraaten, Mads Haugland Haugen

This study examines how the spatial organization of the tumor-immune microenvironment changes during treatment in ER-positive breast cancer and links these changes to clinical response.

bioRxiv · Oct 9, 2025 · PreprintCancer Biology